{"hands_on_practices": [{"introduction": "A hallmark of competitive inhibition is that the inhibitor's effect can be overcome by increasing the substrate concentration. This phenomenon is kinetically described as an increase in the apparent Michaelis constant, $K_{M,app}$. This first exercise provides foundational practice in quantifying this change, allowing you to calculate how the presence of a competitive inhibitor alters the substrate concentration required to reach half of the maximum velocity [@problem_id:2110262].", "problem": "Researchers are investigating a novel therapeutic agent designed to inhibit a specific enzyme implicated in a metabolic disease. This inhibitor is known to bind reversibly to the enzyme's active site, thereby preventing the natural substrate from binding. The Michaelis constant ($K_M$) of the enzyme for its substrate has been determined to be $2.0$ mM. The inhibition constant ($K_i$), which represents the dissociation constant for the enzyme-inhibitor complex, is measured to be $2.5$ mM. In an experiment, the enzyme's activity is assayed in the presence of the inhibitor at a concentration of $5.0$ mM. Under these conditions, the enzyme exhibits modified kinetics, characterized by an apparent Michaelis constant ($K_{M,app}$). Calculate the value of this apparent Michaelis constant. Express your answer in units of mM, rounded to two significant figures.", "solution": "The inhibitor binds reversibly at the active site and competes with the substrate, which corresponds to competitive inhibition. For competitive inhibition, the apparent Michaelis constant increases by the factor $\\alpha$, with\n$$\n\\alpha = 1 + \\frac{[I]}{K_{i}},\n$$\nand the apparent Michaelis constant is\n$$\nK_{M,\\text{app}} = \\alpha K_{M} = K_{M}\\left(1 + \\frac{[I]}{K_{i}}\\right).\n$$\nUsing the given values $K_{M} = 2.0$ mM, $K_{i} = 2.5$ mM, and $[I] = 5.0$ mM, compute\n$$\n\\alpha = 1 + \\frac{5.0}{2.5} = 1 + 2 = 3,\n$$\nso\n$$\nK_{M,\\text{app}} = 3 \\times 2.0\\ \\text{mM} = 6.0\\ \\text{mM}.\n$$\nRounded to two significant figures, the value is $6.0$ in units of mM.", "answer": "$$\\boxed{6.0}$$", "id": "2110262"}, {"introduction": "In experimental biochemistry, we often determine an inhibitor's mechanism not from a given formula, but by analyzing raw kinetic data. Different types of inhibition—competitive, uncompetitive, and non-competitive—leave unique fingerprints on an enzyme's kinetic profile. This practice challenges you to act as an experimentalist, using a set of velocity measurements to deduce the inhibition mechanism, a critical skill for drug characterization and metabolic research [@problem_id:1432075].", "problem": "A team of biochemists is developing a new drug candidate, \"Compound Y-31,\" intended to treat a metabolic disorder caused by the over-activity of a specific enzyme, Fumarate-Malate Dehydrogenase (FMDH). To characterize the interaction of Compound Y-31 with FMDH, they conducted a series of kinetic experiments. The initial reaction velocity ($v_0$) was measured at various concentrations of the substrate, fumarate ($[S]$), both in the absence and in the presence of a fixed concentration of Compound Y-31. The collected data are presented in the table below.\n\n| Substrate Concentration, $[S]$ ($\\mu$M) | Initial Velocity without Inhibitor, $v_0$ ($\\mu$M/min) | Initial Velocity with Inhibitor, $v_0$ ($\\mu$M/min) |\n|:---:|:---:|:---:|\n| 2.0 | 16.7 | 7.4  |\n| 5.0 | 33.3 | 16.7 |\n| 10.0| 50.0 | 28.6 |\n| 20.0| 66.7 | 44.4 |\n| 50.0| 83.3 | 66.7 |\n\nBased on these experimental data, determine the mechanism of inhibition that Compound Y-31 exerts on the FMDH enzyme.\n\nA. Competitive inhibition\n\nB. Non-competitive inhibition\n\nC. Uncompetitive inhibition\n\nD. Substrate inhibition\n\nE. No inhibition", "solution": "We assume Michaelis–Menten kinetics. The initial velocity as a function of substrate concentration is\n$$\nv=\\frac{V_{\\max}[S]}{K_{m}+[S]}.\n$$\nFirst determine $V_{\\max}$ and $K_{m}$ from the data without inhibitor. Using two data points:\n- At $[S]=10$, $v=50$:\n$$\n50=\\frac{V_{\\max}\\cdot 10}{K_{m}+10}\\;\\Rightarrow\\;V_{\\max}=5\\left(K_{m}+10\\right).\n$$\n- At $[S]=20$, $v=66.7$. Interpreting the recurring decimal $66.7$ as $66.\\overline{6}=\\frac{200}{3}$,\n$$\n\\frac{200}{3}=\\frac{V_{\\max}\\cdot 20}{K_{m}+20}\\;\\Rightarrow\\;V_{\\max}=\\frac{200}{3}\\cdot\\frac{K_{m}+20}{20}=\\frac{10}{3}\\left(K_{m}+20\\right).\n$$\nEquating the two expressions for $V_{\\max}$,\n$$\n5\\left(K_{m}+10\\right)=\\frac{10}{3}\\left(K_{m}+20\\right)\\;\\Rightarrow\\;15K_{m}+150=10K_{m}+200\\;\\Rightarrow\\;5K_{m}=50\\;\\Rightarrow\\;K_{m}=10,\n$$\nand then\n$$\nV_{\\max}=5\\left(10+10\\right)=100.\n$$\n\nNow analyze the inhibited data. For competitive inhibition at fixed inhibitor concentration $[I]$, the Michaelis–Menten form is\n$$\nv=\\frac{V_{\\max}[S]}{\\alpha K_{m}+[S]},\\quad \\alpha=1+\\frac{[I]}{K_{i}},\n$$\nso $V_{\\max}$ is unchanged and the apparent Michaelis constant is $K_{m,\\text{app}}=\\alpha K_{m}$. Using $V_{\\max}=100$ and one inhibited datapoint to solve for $K_{m,\\text{app}}$:\n- At $[S]=50$, $v=66.7=66.\\overline{6}=\\frac{200}{3}$,\n$$\n\\frac{200}{3}=\\frac{100\\cdot 50}{K_{m,\\text{app}}+50}\\;\\Rightarrow\\;K_{m,\\text{app}}+50=\\frac{5000}{200/3}=75\\;\\Rightarrow\\;K_{m,\\text{app}}=25.\n$$\nCheck consistency at another substrate concentration:\n- At $[S]=20$, prediction with $V_{\\max}=100$, $K_{m,\\text{app}}=25$ is\n$$\nv=\\frac{100\\cdot 20}{25+20}=\\frac{2000}{45}=\\frac{400}{9}=44.\\overline{4},\n$$\nwhich matches the reported $44.4$. Similarly, at $[S]=10$ the prediction is $v=\\frac{100\\cdot 10}{25+10}=\\frac{1000}{35}=\\frac{200}{7}\\approx 28.6$, at $[S]=5$ it is $v=\\frac{500}{30}=\\frac{50}{3}=16.\\overline{6}$, and at $[S]=2$ it is $v=\\frac{200}{27}=7.\\overline{407}$, all matching the inhibited data.\n\nThus, the inhibited data are exactly described by $V_{\\max}$ unchanged at $100$ and $K_{m}$ increased from $10$ to $25$, i.e., $K_{m,\\text{app}}=\\alpha K_{m}$ with $\\alpha=\\frac{25}{10}=2.5$, which is the hallmark of competitive inhibition. Alternative mechanisms are inconsistent: non-competitive inhibition would decrease $V_{\\max}$ with $K_{m}$ unchanged, and uncompetitive inhibition would decrease both $V_{\\max}$ and $K_{m}$ in the same proportion; neither matches the observed parameter changes.", "answer": "$$\\boxed{A}$$", "id": "1432075"}, {"introduction": "The inhibition constant, $K_i$, serves as a crucial metric for quantifying an inhibitor's potency. In fields like pharmacology and drug design, comparing the $K_i$ values of different compounds is essential for selecting the most effective therapeutic agent. This final problem places you in a drug discovery scenario, where you will use the concept of $K_i$ to determine the relative concentrations of two different inhibitors required to produce the same biological effect, directly linking kinetic theory to practical application [@problem_id:1432092].", "problem": "In a drug discovery program, a research team is investigating two potential therapeutic compounds, named Compound P and Compound Q, designed to inhibit a critical enzyme. This enzyme follows Michaelis-Menten kinetics with a Michaelis constant, $K_M$, of $40.0 \\text{ \\mu M}$ and a maximum velocity, $V_{max}$, of $150.0 \\text{ \\mu M/s}$. Both compounds are found to be competitive inhibitors. Compound P has an inhibition constant, $K_{i,P}$, of $25.0 \\text{ nM}$, while Compound Q has an inhibition constant, $K_{i,Q}$, of $125.0 \\text{ nM}$.\n\nThe therapeutic objective is to administer a sufficient concentration of one of these inhibitors to reduce the enzyme's reaction velocity to precisely 30.0% of its uninhibited velocity. This must be achieved under physiological conditions where the substrate concentration, $[S]$, is stable at $80.0 \\text{ \\mu M}$.\n\nLet $[I_P]$ be the required concentration of Compound P to achieve this therapeutic objective, and let $[I_Q]$ be the required concentration of Compound Q to achieve the same objective. Calculate the dimensionless ratio $\\frac{[I_Q]}{[I_P]}$. Round your final answer to three significant figures.", "solution": "For an enzyme following Michaelis-Menten kinetics with a competitive inhibitor, the rate in the presence of inhibitor at concentration $[I]$ is\n$$\nv=\\frac{V_{\\max}[S]}{\\alpha K_{M}+[S]},\\quad \\text{with}\\quad \\alpha=1+\\frac{[I]}{K_{i}}.\n$$\nThe uninhibited rate is\n$$\nv_{0}=\\frac{V_{\\max}[S]}{K_{M}+[S]}.\n$$\nAt fixed substrate concentration, the fractional activity $r$ under inhibition is\n$$\nr=\\frac{v}{v_{0}}=\\frac{K_{M}+[S]}{\\alpha K_{M}+[S]}.\n$$\nSolving for $\\alpha$ in terms of $r$, $K_{M}$, and $[S]$:\n$$\nr\\left(\\alpha K_{M}+[S]\\right)=K_{M}+[S]\\;\\Rightarrow\\; r\\alpha K_{M}=K_{M}+[S]-r[S]\n$$\n$$\n\\Rightarrow\\;\\alpha=\\frac{K_{M}+(1-r)[S]}{rK_{M}}.\n$$\nRelating $\\alpha$ to inhibitor concentration gives\n$$\n[I]=(\\alpha-1)K_{i}.\n$$\nTherefore, for two competitive inhibitors P and Q that achieve the same target $r$, their required concentrations satisfy\n$$\n[I_{P}]=(\\alpha-1)K_{i,P},\\quad [I_{Q}]=(\\alpha-1)K_{i,Q},\n$$\nand the ratio is\n$$\n\\frac{[I_{Q}]}{[I_{P}]}=\\frac{K_{i,Q}}{K_{i,P}}.\n$$\nSubstituting the given inhibition constants,\n$$\n\\frac{[I_{Q}]}{[I_{P}]}=\\frac{125.0}{25.0}=5.00,\n$$\nwhere the ratio is dimensionless and rounded to three significant figures as required.", "answer": "$$\\boxed{5.00}$$", "id": "1432092"}]}